SQA
WST icon

Simon Quick Advisors’s West Pharmaceutical WST Stock Holding History

Simon Quick Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-710
Closed -$233K – 630
2024
Q4 		$233K Buy
+710
New +$223K 0.01% 407
2020
Q3 		– Sell
-10
Closed -$2K – 514
2020
Q2 		$2K Hold
10
– – ﹤0.01% 424
2020
Q1 		$2K Buy
+10
New +$1.54K ﹤0.01% 431
2017
Q3 		– Sell
-178
Closed -$17K – 539
2017
Q2 		$17K Buy
+178
New +$16.4K 0.01% 200

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Simon Quick Advisors's WST Position: Q1 2025 in Review

Simon Quick Advisors sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 710 shares — an estimated $233K sold.

Simon Quick Advisors first reported a position in WST in Q2 2017 and held it in 4 quarters. The position peaked at $233K in Q4 2024. 715 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Simon Quick Advisors reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Simon Quick Advisors sold 710 West Pharmaceutical shares in Q1 2025, an estimated $233K.
  • Simon Quick Advisors first reported a position in West Pharmaceutical in Q2 2017 and held it in 4 quarters.
  • Simon Quick Advisors's West Pharmaceutical position peaked at $233K in Q4 2024.
  • 715 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Simon Quick Advisors's 13F filing for Q1 2025, filed 15 Apr 2025.